• Ceruletide: Designing Mechanistic Pancreatitis Assays

  2026-09-03

  Ceruletide, also known as Caerulein, is more than a secretagogue: it is a controllable physiological perturbation for linking pancreatic injury to fibrosis mechanisms. This guide shows how the ORM2–ZG16 study can inform assay design, controls, readouts, and model interpretation.

• Gly-Gly-Phe-Gly (GGFG) in Reliable Assays

  2026-09-03

  This scenario-driven guide explains how Gly-Gly-Phe-Gly (GGFG), SKU C8670, can improve control of peptide-conjugate workflows without being mistaken for a direct viability reagent. It connects linker identity, storage, assay controls, interpretation, and vendor selection to practical needs in drug conjugation research and antibody-drug conjugate development.

• CA-074 Me: Reliable Lysosomal Assays

  2026-09-02

  This scenario-driven guide explains how CA-074 Me (Cathepsin B inhibitor), SKU A8239, can improve interpretation of viability, apoptosis, and lysosomal membrane permeabilization assays. It covers formulation, controls, imaging parameters, cathepsin selectivity, and practical product-selection criteria.

• Moxidectin–Polyene Synergy in Oral Candidiasis

  2026-09-02

  A 2024 study found that Moxidectin enhances amphotericin B and nystatin activity against Candida albicans by increasing fungal ergosterol biosynthesis and polyene binding. The work combines isolate testing, transcriptomics, ergosterol-pathway mutants, and a mouse oral candidiasis model to support Moxidectin as a preclinical polyene potentiator rather than a stand-alone antifungal.

• CDK4 Phosphorylation of 4E-BP1 Revealed by PhAXA

  2026-09-01

  Mitchell, Menon, and Garner developed PhAXA, a chemoproteomic strategy for identifying kinase–substrate interactions with phosphorylation-site specificity. The study linked CDK4 to 4E-BP1 phosphorylation, helping explain persistent cap-dependent translation and c-Myc expression during mTORC1 inhibition in breast cancer cell models.

• FLAG tag Peptide: Assay Design for Kinesin

  2026-09-01

  Learn how the FLAG tag Peptide (DYKDDDDK) can be used to build cleaner recombinant protein purification and detection workflows. This guide connects epitope-tag chemistry with assay design principles from recent kinesin activation research.

• Boc-D-FMK Workflows for Apoptosis Research

  2026-08-31

  Boc-D-FMK gives researchers a practical way to test whether caspase activation drives cell death, endothelial inflammation, or hepatocyte injury. This workflow-focused guide combines pathway controls, solubility safeguards, and a reference-informed fibrosis assay strategy for more interpretable results.

• Polymyxin B: From Membrane Damage to Translation

  2026-08-31

  Polymyxin B sulfate is more than a rescue antibiotic model. Its membrane-disruptive activity, immune-signaling effects, and potential to reshape microbiome-aware experimental design make it a valuable reference perturbation for translational infection and immunity research.

• JHU-083 for Glutaminase Pathway Research

  2026-08-30

  JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor designed for selective glutaminase pathway studies in cerebral CD11b cells and experimental cerebral malaria research. This workflow-focused guide shows how to connect glutamate measurements with oxidative-stress assays while avoiding unsupported conclusions in hepatic models.

• Belinostat (PXD101) Workflow for HDAC Research

  2026-08-29

  Build reproducible Belinostat assays around histone acetylation, cell-cycle arrest, and cancer-cell viability rather than relying on a single endpoint. This workflow connects bladder and prostate model benchmarks with a hypothesis-driven extension into acetylation-sensitive spliceosome and DNA-repair studies.

• Anlotinib hydrochloride: Angiogenesis Assay Guide

  2026-08-28

  Anlotinib hydrochloride connects VEGFR2, PDGFRβ, and FGFR1 pharmacology with measurable endothelial phenotypes, making it useful for mechanism-led angiogenesis studies. This guide translates its reported potency into practical migration, tube-formation, signaling, and translational cancer research workflows.

• PYR-41: Decoding E1 Control in Translational Biology

  2026-08-28

  A mechanistic and strategic guide to using PYR-41 to interrogate ubiquitination, NF-κB signaling, antiviral immunity, apoptosis, and inflammation without confusing pathway perturbation with therapeutic validation.

• Thermal Shift Assays for Bacterial Sensor Ligands

  2026-08-27

  This 2025 review explains how thermal shift assays can reveal unknown ligands for bacterial sensor proteins by measuring ligand-induced changes in protein stability. It also defines a practical validation framework that combines soluble ligand-binding domains, pH optimization, controls for assay artifacts, and direct binding measurements such as isothermal titration calorimetry.

• Gepotidacin in Reliable Antibacterial Assays

  2026-08-27

  Gepotidacin (SKU BA1220; GSK2140944) helps researchers distinguish bacterial growth inhibition from nonspecific assay effects through defined concentration, solubility, and mechanistic benchmarks. This scenario-based guide covers assay compatibility, protocol design, data interpretation, and practical vendor selection for antibacterial research.

• PRC2 Recruitment to DNA and RNA Inhibition

  2026-08-26

  Wang and colleagues used reconstituted human PRC2–nucleosome complexes to show that linker DNA, rather than most tested histone features, dominates PRC2 binding under their biochemical conditions. The study also provides a mechanistic explanation for RNA-mediated inhibition: RNA competes with linker DNA for PRC2, sequestering the complex away from nucleosome substrates rather than simply blocking its methyltransferase active site.

7829 records 1/522 page Next 12345 下5页 Last page